Oncogenic RAS induces a distinctive form of non-canonical autophagy mediated by the P38-ULK1-PI4KB axis
Open Access
- 7 March 2025
- journal article
- research article
- Published by Springer Nature in Cell Research
- Vol. 35 (6) , 399-422
Abstract
Cancer cells with RAS mutations exhibit enhanced autophagy, essential for their proliferation and survival, making it a potential target for therapeutic intervention. However, the regulatory differences between RAS-induced autophagy and physiological autophagy remain poorly understood, complicating the development of cancer-specific anti-autophagy treatments. In this study, we identified a form of non-canonical autophagy induced by oncogenic KRAS expression, termed RAS-induced non-canonical autophagy via ATG8ylation (RINCAA). RINCAA involves distinct autophagic factors compared to those in starvation-induced autophagy and incorporates non-autophagic components, resulting in the formation of non-canonical autophagosomes with multivesicular/multilaminar structures labeled by ATG8 family proteins (e.g., LC3 and GABARAP). We have designated these structures as RAS-induced multivesicular/multilaminar bodies of ATG8ylation (RIMMBA). A notable feature of RINCAA is the substitution of the class III PI3K in canonical autophagy with PI4KB in RINCAA. We identified a regulatory P38-ULK1-PI4KB-WIPI2 signaling cascade governing this process, where ULK1 triggers PI4KB phosphorylation at S256 and T263, initiating PI4P production, ATG8ylation, and non-canonical autophagy. Importantly, elevated PI4KB phosphorylation at S256 and T263 was observed in RAS-mutated cancer cells and colorectal cancer specimens. Inhibition of PI4KB S256 and T263 phosphorylation led to a reduction in RINCAA activity and tumor growth in both xenograft and KPC models of pancreatic cancer, suggesting that targeting ULK1-mediated PI4KB phosphorylation could represent a promising therapeutic strategy for RAS-mutated cancers.Keywords
All Related Versions
This publication has 125 references indexed in Scilit:
- Finding the sweet spot: Targeting RAS in tumors while sparing normal tissueCancer Cell, 2024
- The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinomaCancer Letters, 2022
- Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosisCancer Cell, 2021
- Molecular epidemiology and diagnostics of KRAS mutations in human cancerCancer and Metastasis Reviews, 2020
- The Hairpin-type Tail-Anchored SNARE Syntaxin 17 Targets to Autophagosomes for Fusion with Endosomes/LysosomesCell, 2012
- Autophagy and Self-Defense2012
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006
- Identification of a selective ERK inhibitor and structural determination of the inhibitor–ERK2 complexBiochemical and Biophysical Research Communications, 2005
- Computer Visualization of Three-Dimensional Image Data Using IMODJournal of Structural Biology, 1996